Hosted on MSN
Sutro Biopharma’s promising phase 1 study on STRO-004: A potential game-changer in cancer treatment
Sutro Biopharma (STRO) announced an update on their ongoing clinical study. Study Overview: Sutro Biopharma is conducting a Phase 1 open-label study titled A Phase 1 Open-Label Study to Evaluate ...
Nearly a third of US teenagers say they use AI chatbots daily, a new study finds, shedding light on how young people are embracing a technology that’s raised critical safety concerns around mental ...
-- The Hoffman ALS Clinical Trial Awards Program was created to fund early- to mid-stage biomarker-driven clinical trials of novel or repurposed therapeutics for ALS -- MIAMI, Nov. 25, 2025 (GLOBE ...
PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development ...
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 8, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical ...
Have you ever wondered what it’s like to break free from the constraints of mainstream operating systems and step into a world of limitless customization and innovative technology? For many, Linux ...
IT training and certification provider CompTIA launched a new certification designed to help professionals develop and enhance artificial intelligence skills in prompt writing, AI collaboration, and ...
CompTIA has updated its Linux+ certification exam to include new and expanded content on artificial intelligence, automation, cybersecurity, DevOps, infrastructure as code (IaC), scalability, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results